1. Home
  2. ADAM vs SLBT Comparison

ADAM vs SLBT Comparison

Compare ADAM & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adamas Trust Inc.

ADAM

Adamas Trust Inc.

N/A

Current Price

$6.01

Market Cap

702.0M

Sector

Technology

ML Signal

N/A

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$1.21

Market Cap

644.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ADAM
SLBT
Founded
2003
N/A
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
702.0M
644.9M
IPO Year
2003
2025

Fundamental Metrics

Financial Performance
Metric
ADAM
SLBT
Price
$6.01
$1.21
Analyst Decision
Hold
Analyst Count
7
0
Target Price
★ $11.50
N/A
AVG Volume (30 Days)
★ 1.0M
45.0K
Earning Date
10-28-2026
10-26-2026
Dividend Yield
★ 18.35%
N/A
EPS Growth
★ 196.49
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.59
N/A
P/E Ratio
$7.53
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.55
$1.02
52 Week High
$10.36
$6.25

Technical Indicators

Market Signals
Indicator
ADAM
SLBT
Relative Strength Index (RSI) 19.31 33.19
Support Level N/A $1.02
Resistance Level $9.36 $1.75
Average True Range (ATR) 0.31 0.16
MACD -0.09 0.01
Stochastic Oscillator 5.00 28.77

Price Performance

Historical Comparison
ADAM
SLBT

About ADAM Adamas Trust Inc.

Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

Share on Social Networks: